Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complem...
Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE
About this item
Full title
Author / Creator
Wallace, Daniel J , Alexander, Roberta Vezza , O'Malley, Tyler , Khosroshahi, Arezou , Hojjati, Mehrnaz , Loupasakis, Konstantinos , Alper, Jeffrey , Sherrer, Yvonne , Fondal, Maria , Kataria, Rajesh , Powell, Tami , Ibarra, Claudia , Narain, Sonali , Massarotti, Elena , Weinstein, Arthur and Dervieux, Thierry
Publisher
England: Lupus Foundation of America
Journal title
Language
English
Formats
Publication information
Publisher
England: Lupus Foundation of America
Subjects
More information
Scope and Contents
Contents
ObjectiveWe compared the physician-assessed diagnostic likelihood of SLE resulting from standard diagnosis laboratory testing (SDLT) to that resulting from multianalyte assay panel (MAP) with cell-bound complement activation products (MAP/CB-CAPs), which reports a two-tiered index test result having 80% sensitivity and 86% specificity for SLE.Metho...
Alternative Titles
Full title
Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e8603567b6e942a28008ffadbe58890d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e8603567b6e942a28008ffadbe58890d
Other Identifiers
ISSN
2053-8790
E-ISSN
2053-8790
DOI
10.1136/lupus-2019-000349
